Skip to main navigation Skip to search Skip to main content

A CRISPR-Cas13a Based Strategy That Tracks and Degrades Toxic RNA in Myotonic Dystrophy Type 1

Nan Zhang, Brittani Bewick, Guangbin Xia, Denis Furling, Tetsuo Ashizawa

Research output: Contribution to journal › Article › peer-review

20   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'A CRISPR-Cas13a Based Strategy That Tracks and Degrades Toxic RNA in Myotonic Dystrophy Type 1'. Together they form a unique fingerprint.
Sort by

Keyphrases

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology